Following successful appeals from drugmakers, the U.K. is taking another look at whether two new Alzheimer's drugs can be considered cost-effective.
Source
Stat News
Opens original article in a new tab
In Massachusetts, sepsis cases has more than tripled since 2010. Some blame hospitals' use of AI tools for medical coding and billing.
At #STATBreakthrough, top HHS official Chris Klomp talked to STAT about the delicate, high-stakes search for a new CDC director.
The Trump administration is weighing how to respond to a court ruling on vaccine policymaking, a decision that could come with political risks.
(MedPage Today) -- A novel combination of an investigational intravesical drug delivery system designed to provide sustained release of gemcitabine into the bladder (Gem-iDRS, Inlexzo) and systemic treatment with the investigational immunotherapy...